The executive received a phone call from the underwriter on a Tuesday morning. The carrier wanted a sleep study before they would issue the disability insurance policy.

He had told the broker about his CPAP at the application stage. The CPAP was for positional sleep apnea, a condition his doctor described as preventive and mild.

The underwriter saw the CPAP as a signal worth investigating. The case was paused until the executive provided documentation.

Without the sleep study, the policy would either issue with a five-year cap on the benefit period or be declined entirely. With the right kind of sleep study, the carrier would issue the policy at standard terms.

Sixty years of difference between the two outcomes was at stake.

The executive who wears a CPAP for mild positional apnea does not see the device as a disability insurance issue. The cognitive trap is general.

“Optimism bias is how our brains are naturally wired, that somehow or another, everything’s going to be okay. The odds of something bad happening to me are far lower than everyone else around me. That’s a mistaken belief.”

Michael Sir, president and co-founder of One Protection, on the Income Protection Journal Podcast

Sir’s framing fits every executive who discloses a CPAP for the first time on an application without realizing the carrier will read it as evidence of sleep apnea regardless of severity.

This is the underwriting reality for individual disability insurance for executives at most carriers when the medical file mentions a CPAP. The reading can be reversed, but only by introducing additional clinical evidence.

Underwriters of Executive Disability Insurance Read CPAP Usage

Underwriters read a CPAP as evidence of sleep apnea, regardless of why the executive uses one.

Sleep apnea correlates with cardiovascular disease, stroke, and metabolic syndrome, three conditions that drive the carrier’s conservative reading. The actuarial models flag any of those conditions as adjacent risks.

The default reading on a CPAP disclosure is a five-year cap on the benefit period. Some carriers issue a 10-year cap as an intermediate position. Others decline the application entirely.

Severity is not part of the initial reading. The CPAP for mild positional apnea reads the same on the underwriting file as the CPAP for severe obstructive apnea.

The reading is not adjustable without action by the broker. An executive who submits the application and accepts whatever comes back has locked in the cap.

Sleep Study Restores Executive Income Protection

A documented sleep study can reverse the cap. The study has to show three things.

First, the executive’s sleep apnea is mild or positional. Second, the CPAP is being used as a preventive measure. Third, there are no associated cardiovascular concerns.

The apnea-hypopnea index measures the number of breathing interruptions per hour of sleep. An index below 15 is mild. An index above 30 is severe.

Most executives with positional apnea fall well into the mild range.

The reversal does not happen automatically. The broker submits the sleep study to the underwriter, often with a physician’s letter clarifying the preventive nature of the CPAP use.

The reversal path runs through pre-application work, not post-issue appeal.

“The more complicated it is, the more you might want to lean towards doing some pre-underwriting. Before you just apply, you might want to gather some facts. That’s really the bread and butter of what I like to do.”

Steve Eskoz, senior executive account manager at Eugene Cohen Insurance Agency, on the Income Protection Journal Podcast

Eskoz names the broker’s role in CPAP cases specifically. A sleep study paired with a physician’s letter, submitted alongside the application, frames the file the way the underwriter needs to see it.

The physician’s letter typically states the date of diagnosis, the apnea-hypopnea index from the most recent study, the CPAP pressure setting, and a clinical statement about cardiovascular risk. A well-written letter pre-empts the questions the underwriter would otherwise ask.

The underwriter reviews the additional evidence and may remove the cap, partially reduce it, or leave it in place.

The reversal often takes one to two underwriting cycles. If the underwriter declines to remove the cap on the first submission, the broker can request a second-level review or escalate to the medical director.

For an executive who hasn’t yet had a sleep study, the broker can request one before the application reaches the underwriting stage. The study takes one to two weeks to complete and costs roughly $1,000 if not covered by health insurance.

The executive returning the sleep study to the broker before the application is submitted, which is what the Tuesday-morning case turned into, puts the file in the strongest position from the start.

Executive Long Term Disability Insurance Caps

The cap is locked into the policy at issue, similar to how the non-cancellable rate locks at issue. Once the policy issues with a five-year cap, the cap stays in force for the life of the contract.

An executive can pursue an adjustment application after one year of clean medical documentation. The adjustment reopens the medical questions with the carrier, and the cap can be removed if subsequent records support the lower-severity reading.

The adjustment process is broker-led. The executive provides updated medical records and the broker resubmits the case for medical-director review. Reconsideration succeeds often enough that brokers pursue it as a standard step for executives initially rated.

The reconsideration window does not restart the underwriting clock. The original premium, occupation class, and other policy terms stay locked at the issue-age basis. Only the cap is up for review.

For executives who haven’t yet applied, the strongest position is to have the sleep study in hand at the moment of disclosure.

The CPAP becomes a footnote in the file rather than the defining detail.